These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 32935346)

  • 81. Medical treatments of GERD: the old and new.
    Vela MF
    Gastroenterol Clin North Am; 2014 Mar; 43(1):121-33. PubMed ID: 24503363
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [The impact of proton pump inhibitors on esophageal acid exposure in gastroesophageal reflux disease].
    Liang XY; Chen WN; Lan L; Wang Q; Lü YW; Lan Y
    Zhonghua Nei Ke Za Zhi; 2012 Jul; 51(7):513-5. PubMed ID: 22943821
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Recent Advances in the Pharmacological Management of Gastroesophageal Reflux Disease.
    Kung YM; Hsu WH; Wu MC; Wang JW; Liu CJ; Su YC; Kuo CH; Kuo FC; Wu DC; Wang YK
    Dig Dis Sci; 2017 Dec; 62(12):3298-3316. PubMed ID: 29110162
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Randomized Trial of Medical versus Surgical Treatment for Refractory Heartburn.
    Spechler SJ; Hunter JG; Jones KM; Lee R; Smith BR; Mashimo H; Sanchez VM; Dunbar KB; Pham TH; Murthy UK; Kim T; Jackson CS; Wallen JM; von Rosenvinge EC; Pearl JP; Laine L; Kim AW; Kaz AM; Tatum RP; Gellad ZF; Lagoo-Deenadayalan S; Rubenstein JH; Ghaferi AA; Lo WK; Fernando RS; Chan BS; Paski SC; Provenzale D; Castell DO; Lieberman D; Souza RF; Chey WD; Warren SR; Davis-Karim A; Melton SD; Genta RM; Serpi T; Biswas K; Huang GD
    N Engl J Med; 2019 Oct; 381(16):1513-1523. PubMed ID: 31618539
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Problems of nociception in gastroesophageal reflux disease: diagnostics and treatment of irritated oesophagus.
    Sablin OA; Ilchishina TA
    Ter Arkh; 2018 Aug; 90(8):118-124. PubMed ID: 30701946
    [TBL] [Abstract][Full Text] [Related]  

  • 86. New therapies for gastroesophageal reflux disease.
    Bredenoord AJ
    Minerva Gastroenterol Dietol; 2010 Jun; 56(2):129-38. PubMed ID: 20485251
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Comparison of the effect of lansoprazole and omeprazole on intragastric acidity and gastroesophageal reflux in patients with gastroesophageal reflux disease.
    Janczewska I; Sagar M; Sjöstedt S; Hammarlund B; Iwarzon M; Seensalu R
    Scand J Gastroenterol; 1998 Dec; 33(12):1239-43. PubMed ID: 9930385
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Management of GERD: Are Potassium-Competitive Acid Blockers Superior to Proton Pump Inhibitors?
    Kinoshita Y; Ishimura N; Ishihara S
    Am J Gastroenterol; 2018 Oct; 113(10):1417-1419. PubMed ID: 29955116
    [No Abstract]   [Full Text] [Related]  

  • 89. Nocturnal gastroesophageal reflux disease: issues, implications, and management strategies.
    Johnson DA; Katz PO
    Rev Gastroenterol Disord; 2008; 8(2):98-108. PubMed ID: 18641592
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Long-term outcomes of patients with symptomatic gastroesophageal reflux disease treated with vonoprazan.
    Shinozaki S; Osawa H; Kobayashi Y; Sakamoto H; Hayashi Y; Miura Y; Kawarai Lefor A; Yamamoto H
    Scand J Gastroenterol; 2018 Aug; 53(8):897-904. PubMed ID: 30056768
    [TBL] [Abstract][Full Text] [Related]  

  • 91. GERD in 2010: diagnosis, novel mechanisms of disease and promising agents.
    Kandulski A; Malfertheiner P
    Nat Rev Gastroenterol Hepatol; 2011 Feb; 8(2):73-4. PubMed ID: 21293505
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Practice styles, knowledge and attitudes of general practitioners and gastroenterology specialists who treat gastroesophageal reflux disease.
    Carter D; Dickman R
    Medicine (Baltimore); 2018 Dec; 97(52):e13781. PubMed ID: 30593157
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Current pharmacological management of gastroesophageal reflux disease.
    Wang YK; Hsu WH; Wang SS; Lu CY; Kuo FC; Su YC; Yang SF; Chen CY; Wu DC; Kuo CH
    Gastroenterol Res Pract; 2013; 2013():983653. PubMed ID: 23878534
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Potassium-competitive acid blockers, a new therapeutic class, and their role in acid-related diseases: a narrative review.
    Domingues G; Chinzon D; Moraes-Filho JPP; Senra JT; Perrotti M; Zaterka S
    Prz Gastroenterol; 2023; 18(1):47-55. PubMed ID: 37007753
    [TBL] [Abstract][Full Text] [Related]  

  • 95. New and future drug development for gastroesophageal reflux disease.
    Maradey-Romero C; Fass R
    J Neurogastroenterol Motil; 2014 Jan; 20(1):6-16. PubMed ID: 24466441
    [TBL] [Abstract][Full Text] [Related]  

  • 96. An update of pharmacology, efficacy, and safety of vonoprazan in acid-related disorders.
    Savarino V; Antonioli L; Fornai M; Marabotto E; Demarzo MG; Zingone F; Ghisa M; Barberio B; Zentilin P; Ribolsi M; Savarino E
    Expert Rev Gastroenterol Hepatol; 2022 May; 16(5):401-410. PubMed ID: 34550866
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Pharmacologic treatment of GERD in adolescents: Is esophageal mucosal protection an option?
    Romano C; Scarpignato C
    Therap Adv Gastroenterol; 2022; 15():17562848221115319. PubMed ID: 36004307
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Pathophysiology and treatment options for gastroesophageal reflux disease: looking beyond acid.
    Sharma P; Yadlapati R
    Ann N Y Acad Sci; 2021 Feb; 1486(1):3-14. PubMed ID: 33015827
    [TBL] [Abstract][Full Text] [Related]  

  • 99. GERD for the nongastroenterologist: successful evaluation, management, and lifestyle-based symptom control.
    Stein E; Sloan J; Sonu I; Kathpalia P; Jodorkovsky D
    Ann N Y Acad Sci; 2020 Dec; 1482(1):106-112. PubMed ID: 32944973
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Gastroesophageal Reflux Disease: A Review.
    Maret-Ouda J; Markar SR; Lagergren J
    JAMA; 2020 Dec; 324(24):2536-2547. PubMed ID: 33351048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.